Peter Sordillo

Technik-/Wissenschafts-/F&E-Leiter bei SignPath Pharma, Inc.

Consumer Services

Commercial Services

Aktive Positionen von Peter Sordillo

Unternehmen	Position	Beginn	Ende
SignPath Pharma, Inc. SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT.	Technik-/Wissenschafts-/F&E-Leiter	01.06.2017	-
Icahn School of Medicine at Mount Sinai	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
New York University School of Medicine	Corporate Officer/Principal	-	-
Weill Cornell Medical College	Corporate Officer/Principal	-	-

Columbia College (New York)	Undergraduate Degree
New York Medical College	Graduate Degree
New York University	Graduate Degree
The Trustees of Columbia University in The City of New York	Doctorate Degree

International

Vereinigte Staaten

Operativ

Graduate Degree	3
Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1

Sektoral

Consumer Services	8
Commercial Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
SignPath Pharma, Inc. SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT.	Commercial Services

Private Unternehmen

Commercial Services